( MENAFN - Swissinfo) Swiss Pharmaceutical heavyweight Novartis said profit will rise this year as new medicines help offset competition from copycats of its best-selling drug. Core operating profit ...

The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

Swiss pharmaceutical giant Novartis on Friday reported fourth-quarter results after repeatedly raising its full-year guidance ...

If you are having difficulty accessing any content on this website, please visit our Accessibility page. NBA.com is part of Warner Media, LLC’s Turner Sports & Entertainment Digital Network ...

To find the best cloud storage options for photos, we look for services that make uploading and organizing images effortless, while providing ample storage space at an affordable price.

Donald and Melania Trump arrive at the White House ahead of the inauguration ceremony on Monday in Washington, D.C. (Andrew Harnik/Getty Images) Donald Trump was sworn in as the 47th president of ...

The Philadelphia Eagles have had their eyes on this game and more since they fell apart at the end of last season. This has been their reason for every move they made in the offseason. They felt ...

Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking MSN Pharmaceuticals from launching a generic version of Novartis' heart-failure drug Entresto ...

When I look for the best cloud storage for photos, I always look for services that offer plenty of storage space for high-definition photos with secure online backups at a reasonable price.

Entresto’s importance to Novartis is illustrated in the company’s most recent quarterly report, which revealed that the drug generated $5.6 billion in the first three quarters of 2024 ...

We list the best Google Photos alternatives, to make it simple and easy to backup your photos safely and securely. The best Google Photos alternatives offer many of the features found in the ...

WASHINGTON, Jan 16 - Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis' blockbuster heart-failure drug Entresto after a U.S. appeals ...